Concurrent Training on Patients With Type-II DM Associated PAD.
Type 2 Diabetes With Peripheral Angiopathy
About this trial
This is an interventional treatment trial for Type 2 Diabetes With Peripheral Angiopathy focused on measuring Concurrent Exercise Training, Physical Exercise, Glycated hemoglobin, Glycemic control, Insulin Resistance, Type 2 Diabetes Mellitus
Eligibility Criteria
Inclusion Criteria: Age: 40 - 50 years Type-II DM Duration of DM: > 10 years Baseline HbA1C (> 6.6%) Intermittent claudication corresponding to Fontaine Stage IIa PAD by an ABI scale; < 0.9 at rest Had < 160 mmHg SBP and < 105 mmHg DBP Sedentary lifestyle by IPAQ-SF Exclusion Criteria: Smokers Insulin dependent individuals Patients with Complicated cardiovascular disease that might limit their ability to - participate in the intervention period physically (e.g. unstable cardiopulmonary symptoms, ischemic heart failure, or chronic kidney disease) and cancer Any major surgery or revascularization procedure within the previous 1 year In case of a history of severe arthritis that may limit exercise performance Diabetic foot (ulceration or gangrene) Patients with stroke BMI = >30 classified by WHO-Asian as obesity class II Unable to follow the intervention protocol or visit three times per week for exercise Participation in any clinical trial during the past six months Revocation to consent
Sites / Locations
- Uroosa Amin
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Concurrent Training
Aerobic Training
Concurrent training combines aerobic and resistance training within the same session for 30 - 60 minutes, comprising 3 sessions per week for 12 weeks.
Aerobic training for 30 - 60 minutes comprises 3 sessions per week for 12 weeks.